JPM
JPMorgan Chase & Co.
JPM has the edge over MRBK overall, supported by stronger modeled upside and stronger fundamentals.
MRBK
Meridian Corporation
MRBK trails on the overall score without a compensating advantage in the available component scores.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MRBK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
MRBK's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MRBK.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over MRBK in the historical PE scenario, which offers more potential upside but is not a forecast.
MRBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $10.15 | -39% |
| Fair | 8.2x | $13.80 | -16% |
| Current | 9.8x | $16.51 | — |
| Forward | 9.8x | $16.51 | — |
| Expensive | 10x | $17.49 | +5.9% |
Historical ranges are pointers, not guarantees.
MRBK's PE is in its expensive range at 9.8x. On analysts' estimates for next year's earnings, today's price would be 9.8x.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over MRBK on the outlook, with more favorable earnings and revenue expectations.
MRBK Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect MRBK's earnings and profitability to decline, with its revenue holding steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
MRBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.69 | 0% |
| Q3 2026 | $1.69 | -4.5% |
| Q2 2026 | $1.84 | +14% |
| Q1 2026 | $1.85 | +30% |
| Q4 2025 | $1.89 | +30% |
| Q3 2025 | $1.77 | +74% |
| Q2 2025 | $1.61 | +69% |
| Q1 2025 | $1.42 | +34% |
| Q4 2024 | $1.45 | +25% |
MRBK's earnings per share have fallen from their peak: $1.69 over the past year, against $2.96 in mid-2021.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over MRBK on profitability, with a higher operating margin.
MRBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30.1M | -8.9% |
| Q2 2026 | $32.7M | +0.7% |
| Q1 2026 | $30.2M | +12% |
| Q4 2025 | $34.2M | +5.1% |
| Q3 2025 | $33.1M | +14% |
| Q2 2025 | $32.4M | +24% |
| Q1 2025 | $27.1M | +10% |
| Q4 2024 | $32.6M | +30% |
MRBK has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -6.4 points |
| Q2 2026 | 23% | +0.4 points |
| Q1 2026 | 8.6% | -3 points |
| Q4 2025 | 27% | +3.8 points |
| Q3 2025 | 26% | +4.8 points |
| Q2 2025 | 22% | +5.6 points |
| Q1 2025 | 12% | -2.8 points |
| Q4 2024 | 23% | +20 points |
MRBK's operating margin was 20% last quarter, down 6.4 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MRBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $12.4M | -48% |
| Q2 2026 | -$1.4M | +$11.3M |
| Q1 2026 | $2.6M | -85% |
| Q4 2025 | -$6.6M | -$5.5M |
| Q3 2025 | $24M | -27% |
| Q2 2025 | -$12.7M | +$6.6M |
| Q1 2025 | $17.9M | +$21.5M |
| Q4 2024 | -$1.1M | -115% |
MRBK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over MRBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MRBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +48K shares |
| 1 year | +5.9% | +682K shares |
| 3 years | +7.6% | +859K shares |
| 5 years | -1.9% | -240K shares |
MRBK has 12M diluted shares, up 5.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $1,000 |
| Q2 2023 | $1.6M |
| Q1 2023 | $2.7M |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
MRBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2020 | 10.1x | High |
| Q4 2019 | 9.6x | High |
MRBK's net debt is about 10 years of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like MRBK.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MRBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.4 | Neutral |
| Stochastic | 15.5 | Oversold |
MRBK's weekly RSI is 32 (neutral) and its Stochastic is 16 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
MRBK PE vs Financial Services Sector
| Metric | MRBK | Sector median | Relative |
|---|---|---|---|
| PE | 9.8x | 13x | 25% below |
| PE % | 71 | 63 | 8 pts above |
MRBK has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over MRBK on trend strength, trading above more of its moving averages.
MRBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.2 | 9.4% below |
| 20 week MA | $19.1 | 14% below |
| 50 week MA | $18.9 | 13% below |
| 100 week MA | $16.7 | 1% below |
| 200 week MA | $14.2 | 16% above |
MRBK has fallen below most of its moving averages, though it's still 16% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over MRBK on returns for 2026, with the stronger performance.
MRBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.88 | $10.4 | +5.1% |
| 2021 | $10.4 | $17.7 | +70% |
| 2022 | $17.7 | $15.0 | -15% |
| 2023 | $15.0 | $13.9 | -7.5% |
| 2024 | $13.9 | $13.4 | -3.6% |
| 2025 | $13.4 | $17.6 | +31% |
| 2026 YTD | $17.6 | $16.5 | -6.3% |
MRBK has finished lower in three of the last six years. It's down 6.3% so far in 2026.